Daidzin (Daidzein-7-Glucoside · Soy Isoflavone Glycoside · Alcohol Aversion)

Compound	Daidzin (Daidzein-7-O-β-D-Glucoside; 7-Glucosyldaidzein)
Chemical class	Polyphenol — Isoflavone Glucoside (daidzein with glucose at C-7; primary dietary form of daidzein in soy)
CAS	552-66-9
Primary source	Glycine max (soybean — primary dietary form), Pueraria lobata (Kudzu root — co-delivered with puerarin)
Key applications	Dietary isoflavone precursor; ALDH2 inhibition (alcohol aversion mechanism); phytoestrogenic precursor; antioxidant
Claim strength	Moderate
Typical form	Daidzein Powder (aglycone form); Soy Isoflavones 80% (contains daidzin as the glycoside form alongside genistin and glycitin)
Buy from Herbuno	Daidzein Powder → Soy Isoflavones 80% Powder (Soy Extract) | Standardized Glycine max →

Name origin: Daidzin is the 7-O-glucoside of daidzein — "daidzin" adding the "-in" glycoside suffix to the parent aglycone "daidzein." It is the primary dietary form of daidzein in soy foods — raw and lightly processed soy (tofu, soymilk, edamame) predominantly contain the glucoside form (daidzin, genistin, glycitin); fermented soy (miso, natto, tempeh) contains higher proportions of the aglycones (daidzein, genistein, glycitein) due to microbial beta-glucosidase hydrolysis during fermentation. Traditional use: Daidzin's traditional use overlaps with soy food culture broadly. Its specific pharmacological interest arose from Kudzu root research — Pueraria lobata (Ge Gen) contains both daidzin and the C-glucoside puerarin (daidzein-8-C-glucoside) as primary isoflavone constituents, and TCM use of Kudzu for alcohol intolerance and hangover recovery provided the clinical hypothesis for isoflavone-mediated alcohol metabolism modulation. Research trajectory: Daidzin's ALDH2 (aldehyde dehydrogenase 2) inhibitory activity — demonstrated by Keung and Vallee at Harvard in the 1990s — provided a mechanistic explanation for Kudzu's traditional anti-alcohol properties and spawned a research programme investigating isoflavones as alcohol craving and consumption modulators. Unlike disulfiram (Antabuse) which causes aversive acetaldehyde accumulation, daidzin's ALDH2 inhibition operates at a dose-appropriate level to reduce alcohol reward without severe aversive effects. Commercial source: Daidzin is delivered via Daidzein Powder (the aglycone generated from daidzin hydrolysis) and Soy Isoflavones 80% (which contains the full isoflavone spectrum including daidzin as the primary glucoside form) from Herbuno.

---

Evidence for Daidzin Applications

ALDH2 inhibition and alcohol consumption modulation: Daidzin inhibits ALDH2 (mitochondrial aldehyde dehydrogenase) — the enzyme responsible for oxidising acetaldehyde to acetate in alcohol metabolism. ALDH2 inhibition causes acetaldehyde to accumulate, but at daidzin concentrations achievable from botanical preparations, this produces a sub-aversive reduction in alcohol reward rather than the severe flushing and nausea of disulfiram-level ALDH2 inhibition. In golden hamster models (which show alcohol preference analogous to human alcohol use disorder), daidzin dose-dependently reduces alcohol intake without sedation or aversion. Kudzu root preparations (containing daidzin + puerarin) have demonstrated alcohol consumption reduction in multiple human RCTs. Claim strength: Moderate.

Phytoestrogenic precursor activity: Gut beta-glucosidases cleave daidzin's 7-O-glucose to release daidzein aglycone for absorption — the same hydrolysis occurring for all soy isoflavone glucosides. Daidzin therefore functions as the dietary reservoir for daidzein, which is the equol precursor in equol-producing individuals. The phytoestrogenic clinical evidence for soy isoflavone preparations is built on daidzin as the primary dietary delivery form. Claim strength: Moderate.

Antioxidant: Daidzin demonstrates antioxidant activity in DPPH, ABTS, and cellular oxidative stress models, though somewhat lower than the daidzein aglycone due to reduced lipophilicity from the glucose moiety. In plasma, daidzin metabolites (daidzein glucuronides, sulphates) maintain measurable antioxidant capacity for 4–8 hours after ingestion. Claim strength: Moderate.

Cardiovascular and bone: Contributing to the overall soy isoflavone cardiovascular and bone evidence base as the primary dietary delivery form of daidzein. No clinical data exist for daidzin specifically separate from total soy isoflavone preparations. Claim strength: Moderate (mixture).

---

Dosage & Formulator Specification

No isolated daidzin human dosing protocol exists independently of soy isoflavone preparations. In standard soy isoflavone supplements (40–80 mg/day total isoflavones), daidzin contributes approximately 12–24 mg/day as the primary glucoside form. In Kudzu root RCTs for alcohol consumption, preparations providing equivalent of 0.3–1.0 g Kudzu root extract (delivering daidzin alongside puerarin) were effective. Daidzin Powder from Herbuno is the aglycone form (daidzein), not the glucoside — clarification: the product delivers daidzein which is the in vivo equivalent of hydrolysed daidzin.

For formulator specification: Soy Isoflavones 80% delivers the full isoflavone glycoside/aglycone spectrum including daidzin as the primary daidzein conjugate. HPLC analysis of soy isoflavone extracts should report both conjugated (daidzin, genistin, glycitin) and unconjugated (daidzein, genistein, glycitein) forms — their ratio indicates the degree of fermentation/processing. Fermented soy preparations (natto, miso extracts) are enriched in aglycones; non-fermented soy extracts are predominantly glycosides.

Bioavailability of daidzin (glucoside) versus daidzein (aglycone): daidzein is absorbed in the small intestine via passive diffusion; daidzin requires gut beta-glucosidase or microbial cleavage before absorption, delaying peak plasma levels by 1–2 hours. For rapid onset phytoestrogenic or antioxidant effects, aglycone forms (daidzein powder) are preferred; for sustained release and colonic microbiome interaction, glycoside forms (daidzin in Soy Isoflavones 80%) are appropriate.

Safety considerations are those of the soy isoflavone class. The ALDH2 inhibition activity is relevant to product labelling — supplements containing daidzin or Kudzu-derived daidzin should include guidance that the product may interact with alcohol metabolism; users on disulfiram should avoid co-administration.

---

Frequently Asked Questions — Daidzin

What is the difference between daidzin and daidzein?
Daidzin is daidzein-7-O-glucoside — daidzein with a glucose molecule attached at C-7 of the A-ring. Daidzin is the primary dietary form in non-fermented soy foods. Gut enzymes (intestinal beta-glucosidase, colonic bacteria) cleave the glucose to release daidzein aglycone for absorption. Daidzein (the aglycone) is the pharmacologically active form and the equol precursor; daidzin is the stable, water-soluble dietary delivery form that requires hydrolysis before activity.

How does daidzin reduce alcohol consumption without causing the disulfiram reaction?
Disulfiram fully blocks ALDH2, causing severe acetaldehyde accumulation (intense flushing, nausea, cardiovascular effects) — a deliberately aversive reaction. Daidzin is a partial, reversible ALDH2 inhibitor at concentrations achievable from botanical preparations — allowing some acetaldehyde clearance to proceed, reducing the alcohol reward signal (via dopaminergic pathway modulation in the nucleus accumbens) without triggering severe aversive effects. This sub-aversive mechanism targets the reward motivation for drinking rather than creating negative conditioning.

Is daidzin or puerarin more important for Kudzu's alcohol effect?
Both contribute. Daidzin provides the ALDH2 inhibitory mechanism; puerarin (the C-glucoside, resistant to gut hydrolysis and reaching the bloodstream intact) independently modulates dopaminergic and serotonergic pathways relevant to alcohol craving. Human RCT data for Kudzu preparations use the whole root extract delivering both compounds; isolating which is primary requires fractionation studies that have been conducted in animals but not definitively in humans. The current consensus is that the isoflavone complex including both daidzin and puerarin mediates Kudzu's clinical effect.

What form of soy isoflavone is most bioavailable — glycoside (daidzin) or aglycone (daidzein)?
Comparative pharmacokinetic studies consistently show daidzein aglycone has higher Cmax and earlier Tmax than daidzin — absorbed more completely and rapidly in the small intestine by passive diffusion without requiring glycosidase activation. However, daidzin's slower colonic absorption profile may be advantageous for sustained plasma isoflavone levels and enhanced gut microbiome interaction (including equol production). Fermented soy preparations (natto) enriched in aglycones show higher post-meal daidzein Cmax than equivalent doses of non-fermented soy isoflavone glycosides.

Related compounds: Daidzein, Puerarin, Genistein, Glycitein

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery